Rapid Read    •   7 min read

Girard Sharp Investigates Potential Securities Claims Against Neogen Corporation

WHAT'S THE STORY?

What's Happening?

Girard Sharp LLP, a national law firm specializing in investment, securities, and consumer class action litigation, is investigating potential securities claims on behalf of former or current investors of 3M Company. These investors received shares of Neogen Corporation in connection with Neogen's acquisition of 3M's Food Safety Business on September 1, 2022. The investigation focuses on whether the offering materials for the merger included misrepresentations and omissions regarding Neogen's and 3M's financial conditions. Since the merger, Neogen's share price has declined by 75%, and the company has reported significant financial losses, including a net loss of $456.3 million due to a non-cash goodwill impairment related to the acquisition.
AD

Why It's Important?

The investigation by Girard Sharp could have significant implications for Neogen Corporation and its investors. If the firm finds evidence of misrepresentations or omissions in the offering materials, it could lead to legal action and potential financial restitution for affected investors. This situation highlights the risks associated with mergers and acquisitions, particularly when financial conditions are not transparently communicated. The outcome of this investigation could impact investor confidence in Neogen and similar companies, potentially affecting their stock prices and market stability.

What's Next?

Affected investors are encouraged to contact Girard Sharp for a free consultation to explore their legal options. The investigation will likely continue as the firm gathers more information and evidence regarding the merger and the financial disclosures made by Neogen and 3M. Depending on the findings, a class action lawsuit could be filed, which would proceed through the legal system, potentially leading to settlements or court judgments.

AI Generated Content

AD
More Stories You Might Enjoy